News from chantest corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 24, 2013, 08:00 ET
Arthur M. "Buzz" Brown, M.D., Ph.D. is ChanTest's founder, President & CEO, and an Adjunct Professor of Physiology and Biophysics at Case Western Reserve University, School of Medicine. He is a trained cardiologist and physiologist with more than 30 years of experience in ion channels and their relationship to human disease and has published extensively in peer-reviewed journals. Dr. Brown has established world-leading Physiology department at University of Texas Medical Branch, Baylor College of Medicine and Case Western Reserve University.  (PRNewsFoto/ChanTest Corporation)

CEO da ChanTest indicado para receber prêmio de Serviço Distinto pela Safety Pharmacology Society

CLEVELAND, 24 de julho de 2013 /PRNewswire/ - A ChanTest orgulhosamente anuncia que o CEO, presidente e fundador, Arthur "Buzz" Brown, M.D., Ph.D....

Jul 24, 2013, 08:00 ET
Arthur M. "Buzz" Brown, M.D., Ph.D. is ChanTest's founder, President & CEO, and an Adjunct Professor of Physiology and Biophysics at Case Western Reserve University, School of Medicine. He is a trained cardiologist and physiologist with more than 30 years of experience in ion channels and their relationship to human disease and has published extensively in peer-reviewed journals. Dr. Brown has established world-leading Physiology department at University of Texas Medical Branch, Baylor College of Medicine and Case Western Reserve University.  (PRNewsFoto/ChanTest Corporation)

Gerente General de ChanTest nombrado receptor del Distinguished Service Award por la Safety Pharmacology Society

 ChanTest tiene el orgullo de anunciar que su Gerente General, Presidente y Fundador, Arthur "Buzz" Brown, M.D., Ph.D., fue galardonado con...

Jul 24, 2013, 08:00 ET
Arthur M. "Buzz" Brown, M.D., Ph.D. is ChanTest's founder, President & CEO, and an Adjunct Professor of Physiology and Biophysics at Case Western Reserve University, School of Medicine. He is a trained cardiologist and physiologist with more than 30 years of experience in ion channels and their relationship to human disease and has published extensively in peer-reviewed journals. Dr. Brown has established world-leading Physiology department at University of Texas Medical Branch, Baylor College of Medicine and Case Western Reserve University.  (PRNewsFoto/ChanTest Corporation)

La Safety Pharmacology Society décerne au PDG de ChanTest un prix pour services distingués

 ChanTest est fier d'annoncer que son PDG et fondateur, Arthur "Buzz" Brown, M.D., Ph.D., vient d'être nommé récipiendaire du...

Jul 24, 2013, 08:00 ET
Arthur M. "Buzz" Brown, M.D., Ph.D. is ChanTest's founder, President & CEO, and an Adjunct Professor of Physiology and Biophysics at Case Western Reserve University, School of Medicine. He is a trained cardiologist and physiologist with more than 30 years of experience in ion channels and their relationship to human disease and has published extensively in peer-reviewed journals. Dr. Brown has established world-leading Physiology department at University of Texas Medical Branch, Baylor College of Medicine and Case Western Reserve University.  (PRNewsFoto/ChanTest Corporation)

ChanTests CEO von der Safety Pharmacology Society zum Preisträger des Distinguished Service Award ernannt

 ChanTest gab stolz bekannt, dass sein CEO, Präsident und Gründer Dr. med. Arthur „Buzz" Brown von der Safety Pharmacology...

Jul 24, 2013, 08:00 ET
Arthur M. "Buzz" Brown, M.D., Ph.D. is ChanTest's founder, President & CEO, and an Adjunct Professor of Physiology and Biophysics at Case Western Reserve University, School of Medicine. He is a trained cardiologist and physiologist with more than 30 years of experience in ion channels and their relationship to human disease and has published extensively in peer-reviewed journals. Dr. Brown has established world-leading Physiology department at University of Texas Medical Branch, Baylor College of Medicine and Case Western Reserve University.  (PRNewsFoto/ChanTest Corporation)

El consejero delegado de ChanTest es elegido receptor del Distinguished Service Award por la Safety Pharmacology Society

 ChanTest se enorgullece al anunciar que su consejero delegado, director general y fundador, Arthur "Buzz" Brown, doctor y Ph.D., ha sido...

Jul 24, 2013, 08:00 ET
Arthur M. "Buzz" Brown, M.D., Ph.D. is ChanTest's founder, President & CEO, and an Adjunct Professor of Physiology and Biophysics at Case Western Reserve University, School of Medicine. He is a trained cardiologist and physiologist with more than 30 years of experience in ion channels and their relationship to human disease and has published extensively in peer-reviewed journals. Dr. Brown has established world-leading Physiology department at University of Texas Medical Branch, Baylor College of Medicine and Case Western Reserve University.  (PRNewsFoto/ChanTest Corporation)

ChanTest CEO named Distinguished Service Award recipient by the Safety Pharmacology Society

 ChanTest proudly announces that CEO, President and Founder, Arthur "Buzz" Brown, M.D., Ph.D. has been named the recipient of the prestigious...

Oct 15, 2012, 08:00 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest anuncia lançamento de serviços de descoberta de drogas com o uso da biblioteca de compostos Enamine 3D

A ChanTest, Contract Research Organization (CRO - Organização de Pesquisas de Contrato) líder de canal iônico anunciou hoje a...

Oct 15, 2012, 08:00 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest anuncia servicios de descubrimiento de fármacos utilizando la biblioteca de compuestos Enamine 3D

ChanTest, la Organización de Investigación de Contrato (CRO) de canal iónico líder en el sector, anunció hoy la...

Oct 15, 2012, 08:00 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest annonce des services de découverte de médicaments utilisant la bibliothèque 3D de composés d'Enamine

ChanTest, une organisation de recherche sous contrat, leader dans le domaine du canal ionique, annonce aujourd'hui l'ajout d'une bibliothèque...

Oct 15, 2012, 08:00 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest anuncia los servicios de descubrimiento de fármacos que usan la biblioteca de compuestos 3D de Enamine

ChanTest, la organización de investigación por contrato (CRO) de canal de iones líder en la industria, ha anunciado hoy la...

Oct 15, 2012, 08:00 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest kündigt Wirkstoffforschung mit 3D-Substanzbibliothek von Enamine an

ChanTest, führende CRO (Contract Research Organization) für Ionenkanäle gab heute bekannt, dass 50.000 Verbindungen zur...

Oct 15, 2012, 08:00 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest announces drug discovery services using the Enamine 3D compound library

ChanTest, the industry leading ion channel Contract Research Organization (CRO) announces today the addition of a 50,000 compound chemical library...

Aug 17, 2012, 14:10 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest stellt Chris Mathes als Chief Commercial Officer ein

 ChanTest gibt heute die Anstellung von Chris Mathes, Ph.D., M.B.A., bekannt, der zukünftig das Unternehmen in eine neue Ära...

Aug 17, 2012, 13:56 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest contrata a Chris Mathes como Gerente Comercial

 ChanTest anunció hoy la contratación de Chris Mathes, Ph.D., M.B.A., para que dirija su negocio hacia una nueva era. Mathes se...

Aug 17, 2012, 12:23 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest contrata Chris Mathes como diretor comercial

 A ChanTest anunciou hoje a contratação de Chris Mathes, Ph.D., M.B.A., para conduzir os negócios a uma nova era. Mathes...

Aug 17, 2012, 08:00 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest contrata a Chris Mathes como director comercial

 Hoy, ChanTest anuncia la contratación de Chris Mathes, Ph.D., M.B.A. para liderar su negocio hacia una nueva era. Mathes se incorpora el...

Aug 17, 2012, 08:00 ET
ChanTest logo.  (PRNewsFoto/ChanTest Corporation)

ChanTest hires Chris Mathes as Chief Commercial Officer

 Today ChanTest announces the hiring of Chris Mathes, Ph.D., M.B.A. to lead its business into a new era. Mathes starts September 1st as Chief...

Nov 11, 2009, 19:38 ET

Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation

ChanTest, a leading provider of cardiac safety, ion channel, and GPCR services and products for drug discovery and development, today announced...